期刊文献+

观察来曲唑和克罗米芬治疗多囊卵巢综合征不孕对排卵及子宫内膜的影响 被引量:5

下载PDF
导出
摘要 目的探讨来曲唑和克罗米芬治疗多囊卵巢综合征(PCOS)不孕的临床疗效。方法回顾性分析我院2012年8月至2013年10月收治的PCOS不孕患者的资料,随机分为观察组及对照组,各45周期,两组均采用达英-35和二甲双胍治疗好转后,观察组患者用来曲唑(LE),对照组患者用克罗米芬(CC),促排卵.对两组患者治疗后排卵率、优势卵泡率、子宫内膜厚度、妊娠率进行评价。结果观察组患者妊娠率均高于对照组,比较差异有统计学意义(P<0.05);观察组子宫内膜厚度为(7.5±0.8)mm,对照组子宫内膜厚度为(8.7±1.3)mm,比较差异有统计学意义(P<0.05)。排卵率及优势排卵率比较无明显差异(P>0.05)。结论来曲唑在治疗PCOS不孕患者过程中,对成熟卵泡增长活性较高,对子宫内膜影响较轻,临床促排卵优于克罗米芬。
作者 林雪珊
出处 《中国医药指南》 2013年第35期164-165,共2页 Guide of China Medicine
  • 相关文献

参考文献4

二级参考文献24

  • 1张琼,李艳萍.来曲唑治疗克罗米酚促排卵无效三例分析[J].生殖医学杂志,2005,14(4):239-241. 被引量:19
  • 2Mitwally MF, Casper RF. Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate [ J ] . Fertility and Sterility, 2001, 75 (2) : 305.
  • 3Weil S, Vendola K, Zhou J, et al. Androgen and follicle - stimulating hormone interaction in primate ovarian follicle development [ J] . J Clin Endocrinol Metab, 1998, 84 (8): 29515.
  • 4Yen SS, Laughlin GA, Morales AJ. Interface between extra and intra o- varian factors in polycystic ovary syndrome[J] . Ann NY Acad Sci, 1993, 687:98.
  • 5Bayar U, Basaran M, Kiran S, et al. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial [J]. Fertility and Sterility, 2006, 86 (5) : 1447.
  • 6Bayar U, Tanriverdi HA, Barut A, et al. Letrozole vs. clomiphene citrate in patients with ovulatory infertility [J] . Fertility and Sterility, 2006, 86 (6): 1045.
  • 7Jee BC, Ku SY, Suh CS, et al. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study [J] . Feriility and Sterility, 2006, 86 (6): 1774.
  • 8Palomba S, Orio F Jr, Falbo A, el al. Prospective parallel randomized, double-blind, double-dummy controlhd clinical trial composring clomiphene citrate and metfonnin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome [J].Glin Endocrinol Metab,2005, 90(7) :4068 -4074.
  • 9Rouzi AA, Ardawi MS. A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and domiphene citrate in women with clomiphene citrate-resistant polycystic ovary syedrome [J]. Fertil Steril,2006, 85(2) :428 - 435.
  • 10Renato P, Alessandro G. Insulin-sensitizing agents in polycyatic ovary syndrome [J]. Eur J Endocrinol, 2006,154(6) :763 - 775.

共引文献75

同被引文献45

  • 1刘小晴,杨瑞,玛依努尔.尼牙孜.排卵障碍患者用来曲唑与尿促性腺激素方案促排卵对子宫内膜形态的影响的比较[J].兵团医学,2011(3):46-48. 被引量:3
  • 2李莉,章汉旺.芳香酶抑制剂——来曲唑促排卵作用的研究进展[J].生殖与避孕,2006,26(8):486-490. 被引量:17
  • 3王丽娜,乔杰,李蓉,胡卫红.多囊卵巢综合征患者种植窗口期子宫内膜容受性的研究[J].中华妇产科杂志,2007,42(5):298-301. 被引量:10
  • 4谢幸.妇产科学[M].8版.北京:人民卫生出版社,2012:374-386.
  • 5Zhang HY, Guo CX,Zhu FF,et al.Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome :a large - scale case - control study[J].Arch Gynecol Obstet, 2013,287 (3) : 525-531.
  • 6Mourali M,Fkih C,Essoussi-Chikhaoui J,et al.Polycystic ovary syndrome with infertility[J].Tunis Med,2008,86( 11 ): 963-972.
  • 7Panidis D,Tziomalos K,Papadakis E,et al.Infertility treat- ment in polycystic ovary syndrome:lifestyle interventions, medications and surgery[J].Front Horm Res, 2013,40 :128-141.
  • 8Dhaliwal LK, Suri V, Gupta KR,et al.Tamoxifen: an alter- native to clomiphene in women with polycystic ovary syn- drome[J].J Hum Reprod Sci, 2011,4 (2) : 76-79.
  • 9Brezina PR,Mensah V,Balen A,et al.Fertility manage- ment in the PCOS population:results of a web-based sur- vey at IVF-worldwide.com[J].J Assist Reprod Genet,2013, 30(9) : 1169-1174.
  • 10Imani B,Eijkemans MJ,te Velde ER,et al.A nomogram to predict the probability of live birth after clomiphene cit- rate induction of ovulation in normogonadotropic oligomen- orrheic infertility[J].Fertil Steril, 2002,77 ( 1 ) : 91-97.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部